Press releases

Press release 2022/11/21

Medivir recruits Pia Baumann as new Chief Medical Officer

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

Read more

Press release 2022/11/16

Medivir to present at the Redeye Life Science Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

Read more

Press release 2022/11/09

Medivir presents new data on additive efficacy of fostrox in combination with anti-PD1 in nonclinical tumor models at the SITC Immunotherapy Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

Read more

Press release 2022/11/03 Regulatory

MEDIVIR AB – INTERIM REPORT JANUARY – SEPTEMBER 2022

The measures to increase the pace of patient recruitment have yielded results. The Fostrox study is now progressing as expected. July...

Read more

Press release 2022/10/28

Nomination Committee of Medivir appointed

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the nomination committee now has been appointed ahead of the...

Read more

Press release 2022/09/12

Medivir to present at the H.C. Wainwright 24th Annual Global Investment Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

Read more

Press release 2022/09/08

Medivir to present data on additive efficacy of fostrox in combination with anti-PD1 in nonclinical tumor models at the SITC 2022 Annual Meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

Read more

Press release 2022/09/01

Medivir to present at the Pareto Securities´ Healthcare conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Pareto Securities´ Healthcare conference...

Read more

Press release 2022/08/23

Medivir to present at the Erik Penser Bank Company Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Erik Penser Bank Company...

Read more

Press release 2022/08/19 Regulatory

MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2022

The clinical development of fostrox remains our focus  April – June Financial summary for the quarter Net turnover amounted to SEK...

Read more

Press release 2022/05/17

Medivir to present at the ABGSC Life Science Summit

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ABGSC Life Science Summit...

Read more

Press release 2022/05/05 Regulatory

Resolutions at the Annual General Meeting in Medivir on 5 May 2022

Medivir Aktiebolag (publ) held its annual shareholders’ meeting today on 5 May 2022. The annual general meeting was held by physical...

Read more